- Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer
Somayeh Hashemi Sheikhshabani et al, 2024, Cancer Reports CrossRef - Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions
Pierre Vanden Borre et al, 2017, The Oncologist CrossRef - Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
Anna F. Farago et al, 2015, Journal of Thoracic Oncology CrossRef - Infantile NTRK-associated Mesenchymal Tumors
Jessica L Davis et al, 2018, Pediatric and Developmental Pathology CrossRef - Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer
Daniel Richard Gomez et al, 2018, Oncotarget CrossRef - ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid Successfully Treated With Entrectinib: A Case Report and Review of the Literature
Wusheng Zhang et al, 2024, Clinical Lung Cancer CrossRef - Neurotrophic Tyrosine Kinase Gene Fusions: Another Opportunity for Targeting in Lung Cancer
Luis E Raez et al, 2016, Lung Cancer Management CrossRef - The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer
Francesco Passiglia et al, 2016, Expert Opinion on Investigational Drugs CrossRef - Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling
Yang Yang et al, 2016, Oncology Letters CrossRef - New targets bring hope in squamous cell lung cancer: neurotrophic tyrosine kinase gene fusions
Christian Rolfo et al, 2017, Laboratory Investigation CrossRef - Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors
Elke Tatjana Aristizabal Prada et al, 2018, Endocrine-Related Cancer CrossRef - Targeting tropomyosin receptor kinase for cancer therapy
Qi Miao et al, 2019, European Journal of Medicinal Chemistry CrossRef - Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors
Mariana Petaccia de Macedo et al, 2023, Clinical Pathology CrossRef - ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
C. Marchiò et al, 2019, Annals of Oncology CrossRef - β-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer
Hani Lee et al, 2018, Oncogene CrossRef - Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence
Biagio Ricciuti et al, 2017, Medical Oncology CrossRef - Loss of YAP1 defines neuroendocrine differentiation of lung tumors
Takeshi Ito et al, 2016, Cancer Science CrossRef - Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts
Xiaodong Ma et al, 2018, European Journal of Medicinal Chemistry CrossRef - Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer
Nicole Pinto et al, 2014, Journal of Oncology CrossRef - Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt-related transcription factor 2
YUXIANG LIAO et al, 2016, Molecular Medicine Reports CrossRef - Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
Chunwei Xu et al, 2022, Thoracic Cancer CrossRef - Pulmonary Large-Cell Neuroendocrine Carcinoma: Therapeutic Challenges and Opportunities
Georgios Ioannidis, 2020, Forum of Clinical Oncology CrossRef - Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases
Melinda Wuest et al, 2022, EJNMMI Research CrossRef - Targeting TRK family proteins in cancer
Yekaterina B. Khotskaya et al, 2017, Pharmacology & Therapeutics CrossRef - Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial
Koen De Winne et al, 2021, Virchows Archiv CrossRef